NCT06987825Recruiting
Chinese Atrial Fibrillation Registry
Source: ClinicalTrials.gov · Last updated 23 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This prospective, observational cohort study aims to establish a long-term registry of adult patients with atrial fibrillation (AF) in China to comprehensively characterize patient profiles and evaluate real-world management and outcomes over time. The objectives of the study are to: * Describe the demographic, clinical, and treatment characteristics of AF patients across different stages of disease progression. * Assess the effectiveness and safety of various AF treatment strategies, including oral anticoagulation, catheter ablation, and left atrial appendage closure, in routine clinical practice. * Identify patient- and treatment-related factors that influence therapeutic outcomes. * Explore the role of advanced technologies and artificial intelligence in improving procedural performance, risk stratification, and clinical decision-making in AF care. Participants will undergo standardized baseline evaluation and longitudinal follow-up to collect data on heart rhythm monitoring, treatment exposures, healthcare utilization, clinical events, and patient-reported outcomes. This cohort will generate real-world evidence to inform personalized and evidence-based management of AF.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100000 (estimated)
- First submitted
- 16 May 2025
- Start date
- 1 Aug 2011
- Primary completion date
- 31 Dec 2035
- Lead sponsor
- Beijing Anzhen Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06987825
What you commit to
- Study type: Observational
- Planned participants: 100000
- From 1 Aug 2011 to the primary completion date, 31 Dec 2035
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of comorbid conditions associated with an expected life expectancy of less than 1 year
Other
- Atrial fibrillation due to a reversible cause (e.g., transient secondary AF)
Who the study is looking for
- Age ≥ 18 years;
- Documented atrial fibrillation episode lasting \>30 seconds confirmed by electrocardiogram (ECG), Holter monitor, implantable cardiac monitor, or wearable ECG device
- Signed informed consent and willingness to participate in follow-up
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Anzhen Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
| Sir Run Run Shaw Hospital Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
Related publications
- Association Between Baseline Cognitive Impairment and Atrial Fibrillation Recurrence After Catheter Ablation.Pacing Clin Electrophysiol · 2026 · PMID 42864730
- Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation.J Am Heart Assoc · 2026 · PMID 42669879
- Association of left ventricular geometry with outcomes and treatment response in atrial fibrillation and heart failure with preserved ejection fraction.Front Med (Lausanne) · 2026 · PMID 42158122
This page is information, not medical advice. Discuss any trial with your doctor.